John M. Hollingsworth

Episode costs for ambulatory stone surgery vary widelyA study analyzing variation in spending for patients undergoing ureteroscopy or shock wave lithotripsy for urinary stone disease is a step towards helping urologists understand cost reduction opportunities.
Medical expulsive therapy or bust?
Medical expulsive therapy or bust?Whether or not medical expulsive therapy (MET) is a sound recommendation for patients with kidney or ureteral stones is a matter of debate.
New study supports MET for larger ureteric stonesA recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.
Non-adherence to stone meds raises hospitalization riskWhen it comes to urinary stone disease, it appears that prescribers know what they’re doing. According to a study presented at the World Congress of Endourology and SWL in London, non-adherence to kidney stone medications led to a significant increase in adverse health outcomes.
Stone patients are poorly adherent with medical prophylaxisNew findings based on pharmacy claims data show just how adherent patients are to a thiazide, alkali citrate, and allopurinol.
How to talk to patients about prostate cancer screening
How to talk to patients about prostate cancer screeningIn this article, I outline my patient discussion concerning prostate cancer screening, which includes defining what the PSA test is, why to screen or not to screen, the screening controversy, current guidelines, and decision aids.
Expulsive therapy's cost-effectiveness bolstered by analysisPatients who receive medical expulsive therapy as initial management for renal colic incur significantly lower episode-related expenditures than those undergoing early endoscopic stone removal, but are significantly more likely to have return visits to the emergency department.